158 related articles for article (PubMed ID: 16826347)
1. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection.
Matsumoto T; Muratani T; Takahashi K; Ikuyama T; Yokoo D; Ando Y; Sato Y; Kurashima M; Shimokawa H; Yanai S
J Infect Chemother; 2006 Jun; 12(3):145-7. PubMed ID: 16826347
[TBL] [Abstract][Full Text] [Related]
2. Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis.
Matsumoto T; Muratani T; Takahashi K; Ando Y; Sato Y; Kurashima M; Yokoo D; Ikuyama T; Shimokawa H; Yanai S
J Infect Chemother; 2006 Apr; 12(2):97-9. PubMed ID: 16648949
[TBL] [Abstract][Full Text] [Related]
3. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae.
Muratani T; Inatomi H; Ando Y; Kawai S; Akasaka S; Matsumoto T
Int J Urol; 2008 Sep; 15(9):837-42. PubMed ID: 18665871
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae.
Furuya R; Koga Y; Irie S; Ikeda F; Kanayama A; Kobayashi I; Tanaka M
J Infect Chemother; 2013 Dec; 19(6):1218-20. PubMed ID: 23564350
[TBL] [Abstract][Full Text] [Related]
5. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
Matsumoto T
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
[TBL] [Abstract][Full Text] [Related]
6. Should urologists care for the pharyngeal infection of Neisseria gonorrhoeae or Chlamydia trachomatis when we treat male urethritis?
Hamasuna R; Takahashi S; Uehara S; Matsumoto T
J Infect Chemother; 2012 Jun; 18(3):410-3. PubMed ID: 22302695
[TBL] [Abstract][Full Text] [Related]
7. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
[TBL] [Abstract][Full Text] [Related]
8. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections.
Portilla I; Lutz B; Montalvo M; Mogabgab WJ
Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men.
Handsfield HH; Murphy VL
Lancet; 1983 Jul; 2(8341):67-70. PubMed ID: 6134959
[TBL] [Abstract][Full Text] [Related]
10. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
[TBL] [Abstract][Full Text] [Related]
11. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.
Collier AC; Judson FN; Murphy VL; Leach LA; Root CJ; Handsfield HH
Am J Med; 1984 Oct; 77(4C):68-72. PubMed ID: 6093523
[TBL] [Abstract][Full Text] [Related]
13. Single-dose treatment of male patients with gonococcal urethritis using 2g spectinomycin: microbiological and clinical evaluations.
Kojima M; Masuda K; Yada Y; Hayase Y; Muratani T; Matsumoto T
Int J Antimicrob Agents; 2008 Jul; 32(1):50-4. PubMed ID: 18539003
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Neisseria gonorrhoeae isolates from the genital tract and pharynx of two gonorrhea patients.
Saika T; Nishiyama T; Kanayama A; Kobayashi I; Nakayama H; Tanaka M; Naito S
J Infect Chemother; 2001 Sep; 7(3):175-9. PubMed ID: 11810580
[TBL] [Abstract][Full Text] [Related]
15. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
Gratrix J; Bergman J; Egan C; Drews SJ; Read R; Singh AE
Sex Transm Dis; 2013 Nov; 40(11):877-9. PubMed ID: 24113412
[TBL] [Abstract][Full Text] [Related]
16. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.
Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant
Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
[TBL] [Abstract][Full Text] [Related]
18. [Neisseria gonorrhoeae infections].
Furuya R; Tanaka M
Nihon Rinsho; 2009 Jan; 67(1):129-35. PubMed ID: 19177762
[TBL] [Abstract][Full Text] [Related]
19. [Ceftriaxone as a single-dose treatment for male gonococcal urethritis].
Urabe S; Shigematsu S
Jpn J Antibiot; 1984 Nov; 37(11):2169-73. PubMed ID: 6098709
[TBL] [Abstract][Full Text] [Related]
20. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
Unemo M; Golparian D; Potočnik M; Jeverica S
Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
